Accession Number: | 0001104659-22-004129 |
Date: | 2022-01-12 |
Issuer: | ENTRADA THERAPEUTICS, INC. (TRDA) |
Original Submission Date: |
CROWLEY JOHN F
C/O ENTRADA THERAPEUTICS, INC.
6 TIDE STREET
BOSTON, MA 02210
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2022-01-12 | P | 5,000 | a | $9.72 | 5,000 | direct | ||
COMMON STOCK | 2022-01-12 | 0 | $0.00 | 32,864 | indirect | f1 |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | consists of (i) 19,171 shares of common stock and (ii) 13,693 shares of restricted common stock issued upon early exercise of stock options held by john f. crowley 2021 family trust. john f. crowley exercises voting and dispositive power over the shares beneficially owned by john f. crowley 2021 family trust. |